Takara Bio
Presencia
Takara es una de las ...
Takara es una empresa que cotiza bajo el símbolo de cotización 2531 (JP).
Takara tiene presencia directa en 2 países.
Ellos se encuentran en:
- Vinos & Bebidas alcohólicas33%
- Biotecnología33%
- Otro33%
Ejecutivos
Ver el organigrama con sus 13 ejecutivos principales
Biografías más buscadas en Takara Bio
- Koichi Nakao, President, and Chief Executive Officer
- Nobuko Kawashima, Director
- Kazuko Kimura, Director
Crear su alerta
para seguir los movimientos de los ejecutivos en Takara Bio.
Biotecnología
Takara tiene 2.280 competidores entre los que se incluyen Eurofins (Luxemburgo), Lonza (Suiza) y Adaptive Phage Therapeutics (Estados Unidos).
Popular M&A news in Biotecnología
- Metsera acaba de anunciar una recaudación de fondos de 290 millones de dólares. (publicado el 23 de abril de 2024).
- Histogen has filed for bankruptcy protection (publicado el 19 de abril de 2024).
- Bruker has announced the acquisition of NanoString Technologies (publicado el 18 de abril de 2024).
Otros contactos sugeridos en el sector Biotecnología
Noticias
Últimos comunicados de prensa de Takara Bio
- Takara Bio Announces "SonuAAV™", a Novel AAV Vector for Efficient Gene Transfer to the Inner Ear Organ. | News Release | News Release ＆ IR News | Investor Relations
- Construction of the Center for Gene and Cell Processing III, which manufactures mRNA vaccine ingredients and enzymes for mRNA production | News Release | News Release ＆ IR News | Investor RelationsBack ButtonSearch IconFilter IconBack ButtonSearch IconFil
- Takara Bio Announces Publication of Results from NY-ESO-1・siTCR™ Gene Therapy Study in Clinical Cancer Research | News Release | News Release ＆ IR News | Investor Relations
- Takara Bio Announces Presentation of Comparability Studies for CD19 JAK/STAT CAR-T Cell Technology Transfer | News Release | News Release ＆ IR News | Investor Relations
- Takara Bio enters into a license agreement of RetroNectin®with Fondazione Telethon ETS | News Release | News Release ＆ IR News | Investor Relations
- Started using refrigerated boxes for transportation with consideration for the environment | News Release | News Release ＆ IR News | Investor Relations
- Takara Bio Announces Poster Presentation of Data from Clinical Trial of NY-ESO-1・siTCR™ Gene Therapy at ASCO2023 | News Release | News Release ＆ IR News | Investor Relations
- Indian subsidiary acquires ISO13485 certification | News Release | News Release ＆ IR News | Investor Relations
- Takara Bio Announces Initiation of Clinical Trial for Next-Generation CAR-T therapy | News Release | News Release ＆ IR News | Investor Relations
- Announcement of Termination of Co-Development and Exclusive Marketing Agreements with Otsuka Pharmaceutical Co., Ltd. for NY-ESO-1・siTCR™ gene therapy candidate | News Release | News Release ＆ IR News | Investor Relations
- View more press releases Close
Redes sociales sobre Takara Bio
- Takara Bio en Wikipedia, Google News y Yahoo Finance
- Takara Bio en LinkedIn, Twitter y YouTube
Ponerse en contacto
Contactar a través de e-mail con sus ejecutivos Koichi Nakao 
Llame a Takara Bio al +81 77...
